Asia
Heilongjiang ZBD Pharmaceutical Wins Bids for Traditional Chinese Drug Program
Two of Heilongjiang ZBD Pharmaceutical's (SHA:603567) products won bids from China's procurement program for traditional medicines, according to a Thursday filing with the Shanghai bourse.The products include ZBD's quick-acting sugar syrup for children, indicated for fever and sore throat, and its Xiangdan injection for angina pectoris or chest pain, the filing said.
SHA:603567
